Compare Arista Networks Inc (ANET) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Arista Networks IncTrade

Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Arista Networks Inc vs Recursion Pharmaceuticals Inc — how do they compare? Arista Networks Inc trades at $202.75 (market cap $249.53B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Arista Networks Inc is far larger — about 137.9× Recursion Pharmaceuticals Inc's market cap, and Arista Networks Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

	ANET	RXRX
Market Cap	$249.53B	$1.81B
Sector	Technology	Health
52-Week High	$197.85	$6.79
52-Week Low	$116.13	$2.84
Enterprise Value	$236.19B	$1.33B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ANET

Arista Networks downgraded to Hold amid high valuation and risks despite strong AI-driven growth prospects.Seeking Alpha · 1 day agoNeutral Arista Networks beats earnings estimates, driven by hyperscaler spending, supporting a strong buy rating.Seeking Alpha · 3 days agoBullish Arista Networks hits record highs on strong AI data center demand but valuation and margin risks prompt cautious outlook.Seeking Alpha · 3 days agoNeutral View details →

RXRX

Recursion Pharmaceuticals faces slow growth and cash burn despite AI drug discovery partnerships.Seeking Alpha · 1 day agoBearish View details →

About Arista Networks Inc

Arista Networks is a software and hardware provider for the networking solutions sector. Operating as one business unit, software, switching, and router products are targeted for high-performance networking applications, while service revenue comes from technical support. Customer markets include data centers, enterprises, service providers, and campuses. The company is headquartered in Santa Clara, California, and generates most of its revenue in the Americas.

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.